|Articles|November 19, 2015
Michael J. Mauro Discusses the Diagnosis of CML
Author(s)Michael J. Mauro
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5